Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Low drug approvals, high costs, spur RBM adoption

With the expectation of new regulatory guidelines, and the need for increased productivity, companies will need to become “comfortable with data,” says Quintiles executive.

Recipharm to invest €40m in serialization tech ahead of EU and US track and trace rules

Recipharm will invest €40 in serialization equipment to ensure it can comply with evolving track and trace regulations in the US, Europe and other markets.

CRO market to reach $45.2bn by 2022

The global healthcare CRO market is expected to reach $45.2bn by 2022, according to a report by Grand View Research.

Catalent Q2: Softgel growth blighted by Beinheim plant suspension

Suspension of operations at a French softgel facility reduced Catalent’s second quarter revenues by around $21m, but the firm expects full production to restart in March.

Evonik expands silanes distribution deal with Safic-Alcan

Safic-Alcan will sell chemicals used in the synthesis of antibiotics and APIs to drug ingredient firms in Italy under a new deal with Evonik.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...